reports
OPKO Health to Participate in the Jefferies Biotech on the Beach Summi...
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th. Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative. About OPKO Health OPKO is a multinational biopharmaceutic...
Compass Diversified Reports Fourth Quarter and Full Year 2025 Financia...
Compass Diversified Reports Fourth Quarter and Full Year 2025 Financial Results WESTPORT, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market businesses, announced today its consolidated operating results for the three months and full year ended December 31, 2025. “2025 was a challenging year as we navigated the Lugano investigation and completed the related restatement. Despite this, our operating companies, excluding Lugano, delivered solid performance in 2025, reflecting the strength of our diversified ...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financ...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026. Highlights from the fourth quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This n...
Compass Diversified Announces Appointment of Eric Weis as President of...
Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair WESTPORT, Conn., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”), an owner of leading middle market businesses, today announced the appointment of Eric Weis as President of its subsidiary, PrimaLoft Inc. (“PrimaLoft”). Mr. Weis will succeed Anne Cassava who will step down as CEO of PrimaLoft effective February 23, 2026. In addition, Shawn Neville, Chief Executive Officer of BOA Technology, Inc (“BOA”) and a current member of the ...
Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment...
Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board WESTPORT, Conn., Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”), a leading “better-for-you” feminine care brand and subsidiary of Compass Diversified (NYSE: CODI) (“CODI”), announces the appointment of Janis Smith-Gomez as Chair of its Board of Directors, effective January 1, 2026. Ms. Smith-Gomez joined the Company’s Board in April 2024 and has brought commercial and marketing expertise developed through leadership roles a...
Compass Diversified Announces Fourth Quarter and Full Year 2025 Earnin...
Compass Diversified Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information WESTPORT, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that it plans to report financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 26, 2026 after market close. The Company has scheduled a conference call at 5:00 p.m. ET on February 26, 2026 to review its fourth quarter and full year financi...
Moody's Ratings assigns B2 rating to Genesis Energy's new notes
Moody's Ratings (Moody's) assigned a B2 rating to Genesis Energy, L.P.'s (Genesis Energy) proposed senior unsecured notes due 2034. Genesis Energy's existing ratings, including the B1 Corporate Family Rating (CFR), B1-PD Probability of Default Rating (PDR), B2 ratings on its existing senior unsecur...
Moody's Ratings upgrades Genesis Energy's CFR to B1, stable outlook
Moody's Ratings (Moody's) upgraded Genesis Energy, L.P.'s (Genesis Energy) Corporate Family Rating (CFR) to B1 from B2, Probability of Default Rating (PDR) to B1-PD from B2-PD and the ratings on its existing senior unsecured notes to B2 from B3. Concurrently, we changed the company's rating outlook ...
First Bank Announces Strategic Branch Optimization Plan
First Bank Announces Strategic Branch Optimization Plan STRASBURG, Va., Feb. 12, 2026 (GLOBE NEWSWIRE) -- First National Corporation (NASDAQ: FXNC), the parent company of First Bank (the “Bank”), a locally owned and operated community bank, today announced plans to sell two of its banking offices and consolidate three others into nearby locations. These actions are designed to streamline operations, reduce overhead, and allow the Bank to better allocate resources toward delivering enhanced customer service, innovative digital banking solutions, and continued support for the communities it...
OPKO Health to Report Fourth Quarter 2025 Financial Results on Februar...
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-r...
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Clas...
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; o...
First National Corporation Reports Record Fourth Quarter and Annual 20...
First National Corporation Reports Record Fourth Quarter and Annual 2025 Earnings STRASBURG, Va., Jan. 29, 2026 (GLOBE NEWSWIRE) -- First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported consolidated net income of $5.5 million and basic and diluted earnings per common share of $0.61 for the fourth quarter of 2025. For the year ended December 31, 2025, the Company reported consolidated earnings of $17.7 million and basic and diluted earnings per common share of $1.97 and $1.96, respectively, and adjusted...
Altor Completes Sale-Leaseback Transaction Generating Approximately $1...
Altor Completes Sale-Leaseback Transaction Generating Approximately $11 Million in Proceeds WESTPORT, Conn., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”) today announced that its subsidiary, Altor Solutions (“Altor”), a leading designer and manufacturer of custom protective and cold-chain packaging solutions for the industrial and life sciences markets, completed a sale-leaseback transaction involving certain Altor-owned real estate assets, generating approximately $11 million in immediately-available cash proceeds. Altor will continue to operate at the fac...
Moody's Ratings downgrades CODI's CFR to B3, concluding review; outloo...
Moody's Ratings (Moody's) downgraded Compass Group Diversified Holdings LLC's (CODI) Corporate Family Rating (CFR) to B3 from B2, Probability of Default Rating to B3-PD from B2-PD, and the rating on the senior unsecured notes to Caa1 from B3. The rating outlook is negative. Previously, the ratings ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.